STOCK TITAN

EDAP to Present at the Jefferies London Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that CEO Ryan Rhodes will deliver a presentation and host investor meetings at the Jefferies London Healthcare Conference on November 14-16, 2023, in London.
Positive
  • None.
Negative
  • None.

LYON, France, November 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies London Healthcare Conference, which is being held November 14-16, 2023, in London.

Presentation details:

Date: Tuesday, November 14
Time: 9:00 – 9:25 AM GMT
Webcast: Link

The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.

About EDAP TMS SA

A recognized leader in the global therapeutic ultrasound market. EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.comus.hifu-prostate.com and www.focalone.com.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

 


FAQ

Who is delivering the presentation at the Jefferies London Healthcare Conference?

CEO Ryan Rhodes of EDAP TMS SA (Nasdaq: EDAP) is delivering the presentation.

What is the focus of EDAP TMS SA?

EDAP TMS SA is the global leader in robotic energy-based therapies.

When is the Jefferies London Healthcare Conference taking place?

The conference is being held on November 14-16, 2023.

Where is the Jefferies London Healthcare Conference taking place?

The conference is taking place in London.

Where can I access the webcast of the presentation?

The live and archived webcast can be accessed in the Investors section of the Company's website.

EDAP TMS SA

NASDAQ:EDAP

EDAP Rankings

EDAP Latest News

EDAP Stock Data

263.44M
29.56M
43.11%
0.28%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Lyon

About EDAP

global leader in therapeutic ultrasound and present in the market for more than 30 years, edap tms (nasdaq: edap) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology using ultrasound technology. edap tms is actively operating worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. by constantly investing in research & development and partnering with internationally renowned medical research institutions, edap tms has developed a strong valuable patent portfolio based on its innovative technologies. with its complete range of robotic hifu devices, edap tms is the most innovative company in minimally-invasive treatment for localized prostate cancer. by combining the latest technologies in imaging and treatment modalities, edap tms just introduced the focal one® as the answer to all requirements for ideal focal therapy of prostate cancer as a complement to the existing ablatherm® hifu. as a pioneer and ke